Oova logo — The Fertility Translator

Oova

The Fertility Translator

Founded 2017 United States New York, United States 25 employees Series A Total: $12.50M Consumer Goods, Health Care

General Information

Company Name Oova
Founded Year 2017
Location United States New York, United States +1
Employees 25
Industries Consumer Goods, Health Care
Funding Stage Series A
Social

Get notified when Oova moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Oova

Oova is a Consumer Goods and Health Care startup founded in 2017 with the slogan "The Fertility Translator." This innovative company offers a fertility translator for women, providing clear steps to conception. With the backing of Mount Sinai Hospital and a recent $10.30M Series A investment on 12 June 2023 from a consortium of investors including Spero Ventures, Connecticut Innovations, Virgin Group, Jefferson Health System, Samsung NEXT’s Q Fund, Hannah Bronfman, Sara Blakely, US Fertility, and Special Situations Life Sciences Innovation Fund, Oova has established itself as a disruptive player in the industry. The company's at-home urine test measures luteinizing hormone and progesterone, providing immediate information about the most fertile days and confirming ovulation. Oova's consumer-first, data-driven approach offers valuable insights for patients and healthcare providers, delivering advanced personalized analytics and real-time action plans with every hormone reading. Oova is certainly making waves in reshaping the fertility care experience.

Taxonomy: Fertility, Diagnostic, Women's Health, Personalized Medicine, Reproductive Health, Infertility, Luteinizing Hormone, Progesterone, Ovulation, PCOS, Mount Sinai Hospital, Data-driven

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 9
Investor Investor Investor
•••• ••••
12 Jun 2023
Seed Round •••••• 1
Investor
07 Jun 2021
Seed Round •••••• - 13 Mar 2019
Non Equity Assistance •••••• - 01 Jan 2019

Oova Alternatives & Competitors

Oova vs
Proov
Proov United States

Proov offers OTC at-home testing, including the only FDA cleared at-home test to confirm successful...

Series A
22 employees
Biotechnology, Health Care
Oova vs

Hope finds a way.

117 employees
Oova vs

The most advanced fertility monitoring, hormone monitoring and ovulation prediction kit in the marke...

1 employees
Consumer Goods, Health Care

FAQ About Oova

The Fertility Translator
Oova was founded in 2017.
Oova is headquartered in New York, United States.
Oova operates in the following industries: Consumer Goods, Health Care.
Oova has approximately 25 employees.
Oova has completed 4 funding rounds, raising a total of $12.50M. The latest funding stage is Series A.
Top alternatives and competitors to Oova include Proov, New Hope Fertility Center, Pearl Fertility, Natural Cycles°, Vitalogue Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Oova and Proov are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Oova and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy